Urology
Volume 54, Issue 6 , Pages 1120-1125, December 1999

Bicalutamide (Casodex)-induced prostate regression involves increased expression of genes encoding insulin-like growth factor binding proteins☆

  • Tara Nickerson

      Affiliations

    • Department of Medicine, McGill University, Montreal, Quebec, Canada
    • ,
  • Michael Pollak

      Affiliations

    • Department of Medicine, McGill University, Montreal, Quebec, Canada
    • Department of Oncology, McGill University, Montreal, Quebec, Canada
    • Lady Davis Institute of the Jewish General Hospital, Montreal, Quebec, Canada
    • Corresponding Author InformationReprint requests: Michael Pollak, M.D., Lady Davis Institute, 3755 Côte Ste. Catherine Road, Montreal, Quebec H3T 1E2, Canada

Received 15 April 1999; received in revised form 28 June 1999; accepted 28 June 1999.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This study was supported in part by a grant from the National Cancer Institute of Canada to Michael Pollak

PII: S0090-4295(99)00421-5

Urology
Volume 54, Issue 6 , Pages 1120-1125, December 1999

Article Tools

* Image Usage & Resolution